Literature DB >> 24478432

Natural single-nucleotide polymorphisms in the 3' region of the HIV-1 pol gene modulate viral replication ability.

Masako Nomaguchi1, Ariko Miyake, Naoya Doi, Sachi Fujiwara, Yasuyuki Miyazaki, Yasuko Tsunetsugu-Yokota, Masaru Yokoyama, Hironori Sato, Takao Masuda, Akio Adachi.   

Abstract

UNLABELLED: We previously showed that prototype macaque-tropic human immunodeficiency virus type 1 (HIV-1) acquired nonsynonymous growth-enhancing mutations within a narrow genomic region during the adaptation process in macaque cells. These adaptive mutations were clustered in the 3' region of the pol gene, encoding a small portion of the C-terminal domain of integrase (IN). Mutations in HIV-1 IN have been reported to have pleiotropic effects on both the early and late phases in viral replication. cis-acting functions in the IN-coding sequence for viral gene expression have also been reported. We here demonstrated that the adaptive mutations promoted viral growth by increasing virion production with no positive effects on the early replication phase. Synonymous codon alterations in one of the adaptive mutations influenced virion production levels, which suggested nucleotide-dependent regulation. Indeed, when the single-nucleotide natural polymorphisms observed in the 3' regions of 196 HIV-1/simian immunodeficiency virus (SIVcpz) pol genes (nucleotides [nt] 4895 to 4929 for HIV-1 NL4-3) were introduced into macaque- and human-tropic HIV-1 clones, more than half exhibited altered replication potentials. Moreover, single-nucleotide mutations caused parallel increases or decreases in the expression levels of viral late proteins and viral replication potentials. We also showed that the overall expression profiles of viral mRNAs were markedly changed by single-nucleotide mutations. These results demonstrate that the 3' region of the HIV-1 pol gene (nt 4895 to 4929) can alter viral replication potential by modulating the expression pattern of viral mRNAs in a nucleotide-dependent manner. IMPORTANCE: Viruses have the plasticity to adapt themselves under various constraints. HIV-1 can mutate and evolve in growth-restrictive cells by acquiring adaptive changes in its genome. We have previously identified some growth-enhancing mutations in a narrow region of the IN-coding sequence, in which a number of cis-acting elements are located. We now focus on the virological significance of this pol gene region and the mechanistic basis underlying its effects on viral replication. We have found several naturally occurring synonymous mutations within this region that alter viral replication potentials. The effects caused by these natural single-nucleotide polymorphisms are linked to the definite expression patterns of viral mRNAs. We show here that the nucleotide sequence of the pol gene (nucleotides 4895 to 4929 for HIV-1 NL4-3) plays an important role in HIV-1 replication by modulating viral gene expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24478432      PMCID: PMC3993728          DOI: 10.1128/JVI.01859-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.

Authors:  A I Dayton; J G Sodroski; C A Rosen; W C Goh; W A Haseltine
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

2.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

3.  A second post-transcriptional trans-activator gene required for HTLV-III replication.

Authors:  J Sodroski; W C Goh; C Rosen; A Dayton; E Terwilliger; W Haseltine
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function.

Authors:  Venkat S R K Yedavalli; Christine Neuveut; Ya-Hui Chi; Lawrence Kleiman; Kuan-Teh Jeang
Journal:  Cell       Date:  2004-10-29       Impact factor: 41.582

6.  Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase.

Authors:  Kai Zhu; Charles Dobard; Samson A Chow
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Evaluation of the functional involvement of human immunodeficiency virus type 1 integrase in nuclear import of viral cDNA during acute infection.

Authors:  Tamako Ikeda; Hironori Nishitsuji; Xin Zhou; Nobuo Nara; Takashi Ohashi; Mari Kannagi; Takao Masuda
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.

Authors:  Wei-Hao Liao; Chin-Tien Wang
Journal:  Virology       Date:  2004-11-10       Impact factor: 3.616

9.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

Authors:  R L Willey; D H Smith; L A Lasky; T S Theodore; P L Earl; B Moss; D J Capon; M A Martin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

10.  Comparison of SIV and HIV-1 genomic RNA structures reveals impact of sequence evolution on conserved and non-conserved structural motifs.

Authors:  Elizabeth Pollom; Kristen K Dang; E Lake Potter; Robert J Gorelick; Christina L Burch; Kevin M Weeks; Ronald Swanstrom
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

View more
  12 in total

1.  Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels.

Authors:  Masako Nomaguchi; Naoya Doi; Yosuke Sakai; Hirotaka Ode; Yasumasa Iwatani; Takamasa Ueno; Yui Matsumoto; Yasuyuki Miyazaki; Takao Masuda; Akio Adachi
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

2.  In silico Analysis of HIV-1 Env-gp120 Reveals Structural Bases for Viral Adaptation in Growth-Restrictive Cells.

Authors:  Masaru Yokoyama; Masako Nomaguchi; Naoya Doi; Tadahito Kanda; Akio Adachi; Hironori Sato
Journal:  Front Microbiol       Date:  2016-02-09       Impact factor: 5.640

3.  Expression Profiles of Vpx/Vpr Proteins Are Co-related with the Primate Lentiviral Lineage.

Authors:  Yosuke Sakai; Ariko Miyake; Naoya Doi; Hikari Sasada; Yasuyuki Miyazaki; Akio Adachi; Masako Nomaguchi
Journal:  Front Microbiol       Date:  2016-08-03       Impact factor: 5.640

4.  Production of HIV-1 vif mRNA Is Modulated by Natural Nucleotide Variations and SLSA1 RNA Structure in SA1D2prox Genomic Region.

Authors:  Masako Nomaguchi; Naoya Doi; Tomoya Yoshida; Takaaki Koma; Shun Adachi; Hirotaka Ode; Yasumasa Iwatani; Masaru Yokoyama; Hironori Sato; Akio Adachi
Journal:  Front Microbiol       Date:  2017-12-18       Impact factor: 5.640

5.  In silico Analyses of Subtype Specific HIV-1 Tat-TAR RNA Interaction Reveals the Structural Determinants for Viral Activity.

Authors:  Larance Ronsard; Tripti Rai; Devesh Rai; Vishnampettai G Ramachandran; Akhil C Banerjea
Journal:  Front Microbiol       Date:  2017-08-08       Impact factor: 5.640

6.  Role of Ezrin Phosphorylation in HIV-1 Replication.

Authors:  Haruka Kamiyama; Mai Izumida; Yuria Umemura; Hideki Hayashi; Toshifumi Matsuyama; Yoshinao Kubo
Journal:  Front Microbiol       Date:  2018-08-27       Impact factor: 5.640

7.  Role for Gag-CA Interdomain Linker in Primate Lentiviral Replication.

Authors:  Naoya Doi; Takaaki Koma; Akio Adachi; Masako Nomaguchi
Journal:  Front Microbiol       Date:  2019-08-07       Impact factor: 5.640

8.  The Spirocyclic Imine from a Marine Benthic Dinoflagellate, Portimine, Is a Potent Anti-Human Immunodeficiency Virus Type 1 Therapeutic Lead Compound.

Authors:  Mai Izumida; Koushirou Suga; Fumito Ishibashi; Yoshinao Kubo
Journal:  Mar Drugs       Date:  2019-08-24       Impact factor: 5.118

9.  Concomitant Enhancement of HIV-1 Replication Potential and Neutralization-Resistance in Concert With Three Adaptive Mutations in Env V1/C2/C4 Domains.

Authors:  Naoya Doi; Masaru Yokoyama; Takaaki Koma; Osamu Kotani; Hironori Sato; Akio Adachi; Masako Nomaguchi
Journal:  Front Microbiol       Date:  2019-01-17       Impact factor: 5.640

10.  A scale-free analysis of the HIV-1 genome demonstrates multiple conserved regions of structural and functional importance.

Authors:  Jordan P Skittrall; Carin K Ingemarsdotter; Julia R Gog; Andrew M L Lever
Journal:  PLoS Comput Biol       Date:  2019-09-23       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.